These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1355008

  • 1. Reversal of multidrug resistance by two novel indole derivatives.
    Kadam S, Maus M, Poddig J, Schmidt S, Rasmussen R, Novosad E, Plattner J, McAlpine J.
    Cancer Res; 1992 Sep 01; 52(17):4735-40. PubMed ID: 1355008
    [Abstract] [Full Text] [Related]

  • 2. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 3. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD, Carmeli S, Moore RE, Patterson GM.
    Cancer Res; 1993 Mar 15; 53(6):1343-7. PubMed ID: 8095179
    [Abstract] [Full Text] [Related]

  • 4. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep 15; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

  • 5. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM, Arnold ST, Felsted RL, Sinha BK.
    Mol Pharmacol; 1990 Jun 15; 37(6):790-6. PubMed ID: 1972771
    [Abstract] [Full Text] [Related]

  • 6. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL, Wilder PJ, Biswal N.
    Cancer Commun; 1989 Jun 15; 1(3):181-90. PubMed ID: 2576972
    [Abstract] [Full Text] [Related]

  • 7. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts.
    Shudo N, Mizoguchi T, Kiyosue T, Arita M, Yoshimura A, Seto K, Sakoda R, Akiyama S.
    Cancer Res; 1990 May 15; 50(10):3055-61. PubMed ID: 1970752
    [Abstract] [Full Text] [Related]

  • 8. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
    Tatsuta T, Shimizu K, Nishimura T, Suzuki H.
    Anticancer Drug Des; 1991 Jul 01; 6(3):179-88. PubMed ID: 1678605
    [Abstract] [Full Text] [Related]

  • 10. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A, Seth K, Kalra N, Shukla Y.
    Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K, Inoko K, Wakusawa S, Kajita S, Hasegawa T, Takagi K, Koyama M.
    Cancer Res; 1993 Apr 01; 53(7):1555-9. PubMed ID: 8095855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S, Yoshimura A, Kikuchi H, Sumizawa T, Kuwano M, Tahara Y.
    Mol Pharmacol; 1989 Nov 01; 36(5):730-5. PubMed ID: 2573823
    [Abstract] [Full Text] [Related]

  • 18. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B, Prichard RK, Georges E.
    Mol Pharmacol; 1994 Jun 01; 45(6):1145-52. PubMed ID: 7912815
    [Abstract] [Full Text] [Related]

  • 19. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 01; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 20. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
    Borchers C, Ulrich WR, Klemm K, Ise W, Gekeler V, Haas S, Schödl A, Conrad J, Przybylski M, Boer R.
    Mol Pharmacol; 1995 Jul 01; 48(1):21-9. PubMed ID: 7623771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.